Wellfully Ltd
ASX:WFL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its Industry Average (5.8), the stock would be worth AU$-0.02 (766% downside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -0.9 | AU$0 |
0%
|
| Industry Average | 5.8 | AU$-0.02 |
-766%
|
| Country Average | 2.7 | AU$-0.01 |
-405%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| AU |
|
Wellfully Ltd
ASX:WFL
|
1.5m AUD | -0.9 | -1.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
820.3B USD | 30.9 | 39.7 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
542.6B USD | 6.7 | 25.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 7.7 | 20.1 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
216.7B GBP | 5.9 | 28.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
218.2B CHF | 5.9 | 19.6 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
272.8B USD | 5.2 | 14.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
244.4B USD | -58.7 | -83.6 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK | 6 | 11.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
152.3B USD | 1.8 | 19.6 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
116.3B USD | 6.3 | 16.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 2.7 |
| 70th Percentile | 4.3 |
| Max | 2 199.4 |
Other Multiples
Wellfully Ltd
Glance View
Wellfully Ltd. is a science-based wellness company, which engages in the research and development of dermaportation and enhance transdermal polymer technologies. The company is headquartered in Leederville, Western Australia. The company went IPO on 2000-05-29. The firm is focused on research and development for its Dermaportation and Enhanced Transdermal Polymer (ETP) drug delivery technologies. The company is also focused on developing magnetic micro-array and powerless drug delivery technologies and works with partners in the design and development of drug patches, applicators, brushes and devices for the pharmaceutical, healthcare, cosmetic and homecare product sectors. The firm primarily provides these partnering and collaboration services to companies in the United Kingdom, Europe, the United States and South-East Asia. The firm's subsidiaries include International Scientific Pty Ltd, Bodyguard Lifesciences Pty Ltd, Wellfully SA, Wellfully Ltd and Peros Dongguan Technology & Trading Co. Ltd.
